One insider scooped up many shares as Carl Icahn exited his stake in a medical device maker. There were other notable insider ...

Billionaire activist investor Carl Icahn exited stakes in Dana Inc. (NYSE:DAN) and Illumina (NASDAQ:ILMN) in Q2, according to ...

Carl Icahn's 13F shows concentrated equity book, with top 10 holdings making up 98.76%. Notable changes in non-house names ...

Carl Icahn disclosed in a regulatory filing no position in Bausch Health (BHC). Icahn has sold his firm’s entire position in Bausch Health.

Icahn's reportable stock portfolio totaled nearly $28 billion in value as of September 30, 2015. Its top two holdings, Icahn Enterprises L.P. and Apple, made up 48% of the overall portfolio's value.

Bausch Health (BHC) stock rises as board member John Paulson invests $312.5M in the company, boosting his stake by 96%. Carl ...

The company added Brett Icahn and Steven Miller resigned from Bausch Health’s board, following the termination of a separate ...

Unsuccessful short-selling has reportedly put billionaire Carl Icahn's private hedge fund into a six-year-long red streak.

Carl Icahn's son and a portfolio manager for Icahn Capital resigned from the board of Bausch + Lomb after Paulson Capital bought out Icahn Group's shares of its parent company. Brett Icahn and Gary Hu ...

Investing.com -- Bausch Health Companies Inc (NYSE:BHC) stock surged 11.3% after Paulson Capital Inc. and its affiliates increased their ownership stake in the pharmaceutical company.